BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 188001)

  • 1. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathologic analysis of lobular carcinoma of the breast--report of 36 cases].
    Qian H
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):278-81. PubMed ID: 2625110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY; Ren GS; Arnould N; Brettes JP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-needle aspiration cytology of lobular carcinoma in situ.
    Ustün M; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.
    Swain SM
    Oncology (Williston Park); 1989 Mar; 3(3):35-40; discussion 40, 42, 44 passim. PubMed ID: 2561881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
    Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
    Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
    Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
    Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
    Bodian CA; Perzin KH; Lattes R
    Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circumstances in the detection of carcinoma in situ of the breast. Apropos of 12 cases].
    Pangui E; Chevrant-Breton O; Berrada A; Philippe HJ; Kerisit J; Giraud JR; Grall JY
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(4):491-4. PubMed ID: 2850312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE
    J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.